ACCESSION: MSBNK-SMB_Measured-HSA001P0131013
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 103
COMMENT: RAW_SPEC {'BLK02_761': {'bp': 624403.0, 'sum': 1317051.0}, '2_posi_1157': {'bp': 219010.0, 'sum': 715840.0}, 'BLK01_906': {'bp': 232211.0, 'sum': 807280.0}, '1_posi_261': {'bp': 272240.0, 'sum': 857275.0}, '11_posi_909': {'bp': 278146.0, 'sum': 847345.0}, '4_posi_907': {'bp': 283337.0, 'sum': 840498.0}, '15_posi_906': {'bp': 285728.0, 'sum': 815000.0}, 'ProcedureBlank_908': {'bp': 287637.0, 'sum': 822624.0}, '16_posi_576': {'bp': 287677.0, 'sum': 864545.0}, '13_posi_906': {'bp': 297732.0, 'sum': 849826.0}, '1_posi_199': {'bp': 306016.0, 'sum': 893902.0}, 'BLK02_71': {'bp': 308675.0, 'sum': 953879.0}, '6_posi_905': {'bp': 320565.0, 'sum': 866047.0}, '5_posi_908': {'bp': 327345.0, 'sum': 868808.0}, '18_posi_906': {'bp': 337249.0, 'sum': 968496.0}, '13_posi_781': {'bp': 405253.0, 'sum': 921314.0}, '1_posi_323': {'bp': 254519.0, 'sum': 793112.0}, '2_posi_905': {'bp': 263651.0, 'sum': 814811.0}, '1_posi_386': {'bp': 265546.0, 'sum': 824059.0}, '3_posi_579': {'bp': 273477.0, 'sum': 866923.0}, '5_posi_72': {'bp': 294060.0, 'sum': 816783.0}, 'ProcedureBlank_135': {'bp': 297218.0, 'sum': 895131.0}, '4_posi_136': {'bp': 297855.0, 'sum': 954744.0}, 'BLK01_843': {'bp': 305697.0, 'sum': 883812.0}, 'BLK02_576': {'bp': 329069.0, 'sum': 979124.0}, 'ProcedureBlank_845': {'bp': 330094.0, 'sum': 826374.0}, '6_posi_842': {'bp': 380999.0, 'sum': 889412.0}, '1_posi_783': {'bp': 409586.0, 'sum': 918981.0}, 'ProcedureBlank_781': {'bp': 411276.0, 'sum': 931652.0}, '19_posi_764': {'bp': 471293.0, 'sum': 1209915.0}, '1_posi_718': {'bp': 249421.0, 'sum': 825785.0}, '5_posi_327': {'bp': 253297.0, 'sum': 780478.0}, '12_posi_905': {'bp': 304718.0, 'sum': 892139.0}, '12_posi_86': {'bp': 306870.0, 'sum': 926636.0}, '5_posi_784': {'bp': 307810.0, 'sum': 754622.0}, '12_posi_845': {'bp': 320263.0, 'sum': 787140.0}, '11_posi_845': {'bp': 349219.0, 'sum': 867426.0}, '3_posi_780': {'bp': 383957.0, 'sum': 885033.0}, '2_posi_967': {'bp': 251325.0, 'sum': 781616.0}, '2_posi_400': {'bp': 253984.0, 'sum': 765684.0}, '1_posi_906': {'bp': 275521.0, 'sum': 843799.0}, '3_posi_905': {'bp': 279595.0, 'sum': 827037.0}, '15_posi_843': {'bp': 283937.0, 'sum': 741702.0}, '2_posi_150': {'bp': 304353.0, 'sum': 935058.0}, '1_posi_137': {'bp': 304631.0, 'sum': 887864.0}, '2_posi_88': {'bp': 307732.0, 'sum': 942253.0}, '4_posi_72': {'bp': 310539.0, 'sum': 954320.0}, '7_posi_85': {'bp': 311134.0, 'sum': 945654.0}, '7_posi_149': {'bp': 313650.0, 'sum': 922951.0}, '2_posi_842': {'bp': 326321.0, 'sum': 810392.0}, '16_posi_827': {'bp': 328586.0, 'sum': 812852.0}, '14_posi_908': {'bp': 330406.0, 'sum': 866681.0}, '18_posi_843': {'bp': 332806.0, 'sum': 826924.0}, 'BLK02_824': {'bp': 340352.0, 'sum': 875551.0}, '7_posi_783': {'bp': 358145.0, 'sum': 853933.0}, '5_posi_845': {'bp': 372002.0, 'sum': 917928.0}, '4_posi_783': {'bp': 380578.0, 'sum': 910066.0}, '4_posi_845': {'bp': 384664.0, 'sum': 959276.0}, '10_posi_782': {'bp': 420995.0, 'sum': 952634.0}, 'BLK02_1014': {'bp': 244553.0, 'sum': 805945.0}, '7_posi_905': {'bp': 255152.0, 'sum': 762584.0}, '5_posi_134': {'bp': 256897.0, 'sum': 798229.0}, '1_posi_845': {'bp': 265514.0, 'sum': 733147.0}, '9_posi_85': {'bp': 271088.0, 'sum': 851701.0}, '4_posi_259': {'bp': 282591.0, 'sum': 841385.0}, '9_posi_212': {'bp': 285452.0, 'sum': 862059.0}, '8_posi_843': {'bp': 285639.0, 'sum': 775464.0}, '3_posi_134': {'bp': 296827.0, 'sum': 954420.0}, '19_posi_887': {'bp': 298769.0, 'sum': 864195.0}, '17_posi_843': {'bp': 305266.0, 'sum': 853149.0}, '3_posi_70': {'bp': 316699.0, 'sum': 960548.0}, '1_posi_73': {'bp': 332907.0, 'sum': 943091.0}, '7_posi_845': {'bp': 336540.0, 'sum': 844314.0}, '2_posi_780': {'bp': 366966.0, 'sum': 839919.0}, '13_posi_845': {'bp': 380118.0, 'sum': 903901.0}, '14_posi_782': {'bp': 412947.0, 'sum': 906084.0}, '12_posi_782': {'bp': 413334.0, 'sum': 964921.0}, '17_posi_781': {'bp': 433750.0, 'sum': 980941.0}, '15_posi_782': {'bp': 527454.0, 'sum': 1155220.0}, '8_posi_135': {'bp': 280019.0, 'sum': 890113.0}, '2_posi_339': {'bp': 284485.0, 'sum': 842517.0}, '8_posi_907': {'bp': 285235.0, 'sum': 841182.0}, '8_posi_73': {'bp': 292997.0, 'sum': 923614.0}, '13_posi_580': {'bp': 305887.0, 'sum': 931859.0}, '14_posi_846': {'bp': 340273.0, 'sum': 828692.0}, '3_posi_845': {'bp': 351261.0, 'sum': 874572.0}, '8_posi_781': {'bp': 372120.0, 'sum': 888948.0}, '11_posi_782': {'bp': 432416.0, 'sum': 987664.0}, '9_posi_843': {'bp': 445469.0, 'sum': 1029071.0}, '16_posi_764': {'bp': 448056.0, 'sum': 1034092.0}, '10_posi_845': {'bp': 306682.0, 'sum': 845334.0}, '19_posi_825': {'bp': 348437.0, 'sum': 881721.0}, '9_posi_780': {'bp': 461765.0, 'sum': 1033060.0}, '14_posi_969': {'bp': 246704.0, 'sum': 732717.0}, '16_posi_889': {'bp': 354809.0, 'sum': 898919.0}, '18_posi_781': {'bp': 433927.0, 'sum': 1006755.0}, '10_posi_905': {'bp': 260581.0, 'sum': 788238.0}, '2_posi_27': {'bp': 315776.0, 'sum': 946769.0}, '6_posi_780': {'bp': 413442.0, 'sum': 984667.0}, 'BLK02_886': {'bp': 320531.0, 'sum': 878079.0}, 'ProcedureBlank_970': {'bp': 264254.0, 'sum': 784152.0}, 'BLK01_780': {'bp': 302390.0, 'sum': 954809.0}, '5_posi_197': {'bp': 264443.0, 'sum': 813456.0}}
COMMENT: RETENTION_TIME_STDEV 0.636
COMMENT: PRECURSOR_M/Z_RAW 131.081268
COMMENT: PRECURSOR_M/Z_STDEV 0.000036
COMMENT: PRECURSOR_IN_MS1 mz 131.081496; int 126.365; delta(ppm) 1.382444
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.077; C5H10N2O2; [M+H]+; delta(ppm) -0.076879
COMMENT: PROPOSED_MF MS-FINDER 4.431; C5H10N2O2; [M+H]+; delta(ppm) -0.076362
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.752; C5H10N2O2; [M+H]+; delta(ppm) -0.076362
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.118; C3H8N5O; [M+H]+; delta(ppm) 10.166709
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H10N2O2; [M+H]+; delta(ppm) -0.076362
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.826; WBRYLZHYOFBTPD-YDFGWWAZSA-N; [M+H]+; UNPD97725
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.821; OUCUOMVLTQBZCY-UHFFFAOYNA-N; [M+H]+; D-1-Amino-2-pyrrolidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.818; SHINASQYHDCLEU-PWECYVOMNA-N; [M+H]+; trans-4-Aminoproline;(-)-trans-4-Aminoproline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.811; DWAKXSZUASEUHH-MLHKIVSYNA-N; [M+H]+; Cucurbitine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.764; VJLXSTXGGXYQCT-UHFFFAOYNA-N; [M+H]+; L-cis-3-Amino-2-pyrrolidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.687; LSCGXMRADGYVRI-SGAVLPGINA-N; [M+H]+; UNPD120182
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.678; BZIBRGSBQKLEDC-SGAVLPGINA-N; [M+H]+; UNPD110775
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.670; JSSXHAMIXJGYCS-SCSAIBSYSA-N; [M+H]+; (R)-piperazine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.670; RCCYSVYHULFYHE-UHFFFAOYSA-N; [M+H]+; UNPD140145
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.659; RFIOZSIHFNEKFF-UHFFFAOYSA-N; [M+H]+; piperazine-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.642; HBAIZGPCSAAFSU-UHFFFAOYSA-N; [M+H]+; 1-(2-hydroxyethyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.630; SKYSFPFYQBZGDC-IMJSIDKUSA-N; [M+H]+; (3S,4S)-3-amino-1-hydroxy-4-methylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.618; FJMAXCRRCJSCIE-UHFFFAOYSA-N; [M+H]+; N-acetylglycine-N-methylamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.566; FAYGHIHBKVQGDC-UHFFFAOYSA-N; [M+H]+; 4-amino-5-oxopentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.566; ZKWFSTHEYLJLEL-UHFFFAOYSA-N; [M+H]+; morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; LSCGXMRADGYVRI-SGAVLPGINA-N; [M+H]+; UNPD120182
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WBRYLZHYOFBTPD-YDFGWWAZSA-N; [M+H]+; UNPD97725
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SKYSFPFYQBZGDC-IMJSIDKUSA-N; [M+H]+; (3S,4S)-3-amino-1-hydroxy-4-methylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; OUCUOMVLTQBZCY-UHFFFAOYNA-N; [M+H]+; D-1-Amino-2-pyrrolidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; VJLXSTXGGXYQCT-UHFFFAOYNA-N; [M+H]+; L-cis-3-Amino-2-pyrrolidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; DWAKXSZUASEUHH-MLHKIVSYNA-N; [M+H]+; Cucurbitine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; SHINASQYHDCLEU-PWECYVOMNA-N; [M+H]+; trans-4-Aminoproline;(-)-trans-4-Aminoproline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; FJMAXCRRCJSCIE-UHFFFAOYSA-N; [M+H]+; N-acetylglycine-N-methylamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; JSSXHAMIXJGYCS-SCSAIBSYSA-N; [M+H]+; (R)-piperazine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; RFIOZSIHFNEKFF-UHFFFAOYSA-N; [M+H]+; piperazine-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; HBAIZGPCSAAFSU-UHFFFAOYSA-N; [M+H]+; 1-(2-hydroxyethyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; BZIBRGSBQKLEDC-SGAVLPGINA-N; [M+H]+; UNPD110775
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; RCCYSVYHULFYHE-UHFFFAOYSA-N; [M+H]+; UNPD140145
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; FAYGHIHBKVQGDC-UHFFFAOYSA-N; [M+H]+; 4-amino-5-oxopentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.797; ZKWFSTHEYLJLEL-UHFFFAOYSA-N; [M+H]+; morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.047; ZKWFSTHEYLJLEL-UHFFFAOYSA-N; [M+H]+; morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.863; JSSXHAMIXJGYCS-UHFFFAOYSA-N; [M+H]+; piperazine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.228; OUCUOMVLTQBZCY-UHFFFAOYSA-N; [M+H]+; 1-aminopyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.735; HBAIZGPCSAAFSU-UHFFFAOYSA-N; [M+H]+; 1-(2-hydroxyethyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.539; WBRYLZHYOFBTPD-UHFFFAOYSA-N; [M+H]+; N-(4-hydroxyiminopentan-2-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.466; LSNOAQQZECGQNS-UHFFFAOYSA-N; [M+H]+; morpholine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.356; DIKLYCVDFLTLOP-BYPYZUCNSA-N; [M+H]+; (2S)-2-amino-5-iminopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.320; DWAKXSZUASEUHH-UHFFFAOYSA-N; [M+H]+; 3-aminopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.288; DLRQZSOHVPOGGS-UHFFFAOYSA-N; [M+H]+; 1-nitrosopiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.252; WBLAGXUBLXMTAS-DAXSKMNVSA-N; [M+H]+; (2Z)-2-hydroxyiminopentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.251; PNCOVHJMURHEPK-UHFFFAOYSA-N; [M+H]+; 3-amino-1-hydroxypiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; MQHAXHRKPMZBQN-UHFFFAOYSA-N; [M+H]+; N'-hydroxyoxolane-3-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.224; QCVPQZJTIBYSOX-UHFFFAOYSA-N; [M+H]+; 1-nitrosopiperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.122; YPSPPJRTCRMQGD-UHFFFAOYSA-N; [M+H]+; morpholine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.122; LLGRORFWHFVNIK-UHFFFAOYSA-N; [M+H]+; oxolane-2-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; BZIBRGSBQKLEDC-BYPYZUCNSA-N; [M+H]+; (3S)-diazinane-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.063; QGVWIIQJCHMZSJ-UHFFFAOYSA-N; [M+H]+; 2-(3-aminooxetan-3-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.061; DQLGPMHNSVSHQZ-UHFFFAOYSA-N; [M+H]+; oxolane-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; RRAANKOMZXHCIN-UHFFFAOYSA-N; [M+H]+; 6-(aminomethyl)morpholin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; AOUYCCFUYHPVGG-SCSAIBSYSA-N; [M+H]+; (6R)-6-(hydroxymethyl)piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; UYZGJJIHZKHDTQ-UHFFFAOYSA-N; [M+H]+; 3-aminooxolane-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; FUIVIYZQYPWELC-UHFFFAOYSA-N; [M+H]+; 5-hydroxy-1-methyl-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; VJLXSTXGGXYQCT-UHFFFAOYSA-N; [M+H]+; 3-aminopyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; FWKZXDXFGJTECF-UHFFFAOYSA-N; [M+H]+; azetidin-3-yl N-methylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; DQAVTPNFFSXYDH-UHFFFAOYSA-N; [M+H]+; methyl N-(azetidin-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.048; WYZFWCBQXQXNDS-IUYQGCFVSA-N; [M+H]+; (3R,5S)-3-amino-5-(hydroxymethyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.048; GPUZXRISKZMMQG-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-4-methyl-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; RMNHPXDNGOBDOT-IMJSIDKUSA-N; [M+H]+; (3S,4R)-4-aminopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; KZGJDCTWVFBAPY-UHFFFAOYSA-N; [M+H]+; (1-nitrosopyrrolidin-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; WRUMOCUMNFEQKU-UHFFFAOYSA-N; [M+H]+; 6-amino-1,4-oxazepan-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; NVMPGZVKUQCGLJ-UHFFFAOYSA-N; [M+H]+; 2-[3-(2-hydroxyethyl)diazirin-3-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; CLMHBZXXCPPCOH-UHFFFAOYSA-N; [M+H]+; 3-methoxyazetidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; XDESMOSWSZWTAM-IUYQGCFVSA-N; [M+H]+; (3R,4S)-4-aminooxolane-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.993; HSDKTLKBDJXJQU-UHFFFAOYSA-N; [M+H]+; ethyl 3-amino-3-iminopropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; BCYJOUHCNAGXGJ-UHFFFAOYSA-N; [M+H]+; 4-amino-2-ethyl-1,2-oxazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.889; FKAGNGDVPDABRM-UHFFFAOYSA-N; [M+H]+; 1-(nitrosomethylamino)butan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.889; JQITYOMGMPUHKZ-UHFFFAOYSA-N; [M+H]+; 4-(nitrosomethylamino)butan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.840; NRDFNXRMQZOSLW-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(1,2-oxazolidin-2-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; WIRPTIGYRJIAOA-YFKPBYRVSA-N; [M+H]+; (1R)-1-cyclopropyl-2-nitroethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.803; DHBLPXDQGFMAFX-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.792; CTCJZEIJGYQHQH-SCSAIBSYSA-N; [M+H]+; (5R)-5-(aminomethyl)-3-methyl-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.791; XKVAJOLMMZXXMN-UHFFFAOYSA-N; [M+H]+; methyl 4-amino-4-iminobutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.785; XEXOFGFFYFCFLM-UHFFFAOYSA-N; [M+H]+; methyl 3-aminoazetidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; RVAATVPDNLJZNU-UHFFFAOYSA-N; [M+H]+; methyl N-amino-N-cyclopropylcarbamate
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C5H11N2O2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.304
MS$FOCUSED_ION: PRECURSOR_M/Z 131.081494
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03e9-1900000000-ee47c30c700d4826451f
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  70.0650905 41.5496 70.065710 1.3702 16.94 -0.4733 103 f{C4H8N1}/-0.50ppm,p-C1H3N1O2
  71.0602868 25.6001 71.060900 0.9992 9.41 -0.0785 103 f{C3H7N2}/-1.24ppm,p-C2H4O2
  72.0444135 209.2406 72.045020 0.4164 65.15 -0.5537 103 f{C3H6N1O1}/0.32ppm,p-C2H5N1O1
  85.0760608 58.8705 85.076540 1.1049 12.23 0.1388 103 f{C4H9N2}/0.42ppm,p-C1H2O2
  86.0600533 106.3603 86.060520 0.6739 44.40 -0.2634 103 f{C4H8N1O1}/0.15ppm,p-C1H3N1O1
  113.0709664 606.7902 113.071160 0.3007 36.54 0.9307 103 f{C5H9N2O1}/0.24ppm,p-H2O1
  114.0549876 534.8828 114.055170 0.3244 187.05 -0.5740 103 f{C5H8N1O2}/0.29ppm,p-H3N1
  114.0912680 18.2262 114.091450 2.2789 6.45 -0.1383 98 ?
  131.0815473 999.0000 131.081500 0.3052 0.00 1.0000 103 f{C5H11N2O2}/0.33ppm,p
  131.1624885 33.6913 131.162440 1.3876 8.81 0.3323 102 ?
PK$NUM_PEAK: 10
PK$PEAK: m/z int. rel.int.
  70.065090 41.55 41
  71.060287 25.60 25
  72.044413 209.24 209
  85.076061 58.87 58
  86.060053 106.36 106
  113.070966 606.79 606
  114.054988 534.88 534
  114.091268 18.23 18
  131.081547 999.00 999
  131.162489 33.69 33
//
